What We’re Reading: Purdue to Pay $8 Billion; "Close Contact" Definition Broadened; Ireland Reimposes Lockdown
Greater Green Tea, Coffee Consumption Associated With Lower Mortality Risk in T2D Population
Dr Peter McAllister on How COVID-19 Has Impacted Migraine Prevention Efforts
Patients With MM Living Longer, but Elderly Still Face Worse Survival
Key Updates and Limitations of Guidelines to Treat Asthma
Succeeding in Value-Based Payment Requires Engaging Pharmacists From Health Plans and Systems
Study Finds Solriamfetol Effective, Safe as Treatment of Excessive Daytime Sleepiness
Dr Nicola Hanania: Patient, Clinician Collaboration Is Key to Choosing Optimal Biologic Therapy
Examining Payer Strategies, Impact on Managing Specialty Medications
Real-World Evidence in Oncology Must Be Timely for Use in Payer Decisions
Drops in Circulating MicroRNA-451a Could Be Sign of MM Relapse
Dr Megan Althoff on the Difficulties Deciding Between Biologics for Patients With Severe Asthma
Dr David Jackman on Dana Farber's Clinical Pathway Development Process
Diagnosing ARDS Earlier and the Development of ICU Delirium in Patients With ARDS
Daniel Nam on Post–COVID-19 Implications for Managed Care Pharmacy
Review Lays Out the Tough Task of Discerning T-cell Prolymphocytic Leukemia
What We’re Reading: Optimism From NIH Director; Finding, Trusting COVID-19 Info; Alarm in Alaska
Keeping Up With Pharmacists’ Changing Scope of Practice Amid COVID-19
Planning for the Next COVID-19 Surge and Preventing a Crisis Care Scenario
SGLT2 Inhibitors Shine as Therapy for Patients With Heart Failure
Dr Dan Ouellette: New Asthma Guidelines Help to Fill a Treatment Gap
Air Pollution Tied to Higher Hospitalization Risk for PD, Other Neurological Disorders
Current Management of Chronic Cough and Emerging Therapies
Makary Calls for Price Reform, Transparency to Fulfill Patient-Centered Medical Heritage
What We're Reading: Stimulus Deadline; New Mental Health Hotline; Coronavirus Standard of Care
How Maryland Optimized Data Analytics to Target COVID-19 Outreach to Vulnerable Populations
Dr Krishna Sundar Previews His Discussion on Management of Chronic Cough
Researchers Estimate Lifetime Outcomes of Anti-VEGF Treatment for nAMD
Dr Timothy Yap Reiterates the Unmet Medical Need for Molecularly Targeted Agents in Solid Tumors
Improving Transitions of Care in the ICU